Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–13 of 13 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT05995015
- Conditions
- B Cell Malignancies
- Locations
-
- Shenzhen Geno-Immune Medical Institute Shenzhen, Guangdong, China
Recruiting
CD19/22 Bi-specific CAR-T Cell Therapy
NCT05432882
- Conditions
- B Cell Malignancies
- Locations
-
- Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China
Recruiting
CD19/79b Bi-specific CAR-T Cell Therapy
NCT05436509
- Conditions
- B Cell Malignancies
- Locations
-
- Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China
Recruiting
CD19/70 Bi-specific CAR-T Cell Therapy
NCT05436496
- Conditions
- B Cell Malignancies
- Locations
-
- Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China
NCT07135466
- Conditions
- B Cell Malignancies, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Sheba Medical Center Ramat Gan, G, Israel
NCT06375161
- Conditions
- B Cell Malignancies
- Locations
-
- Shanghai Tongji Hospital Shanghai, Shanghai Municipality, China
Not Yet Recruiting
A Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies
NCT07503353
- Conditions
- Acute Lymphobkastic Leukemia, B Cell Malignancies, Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell)
- Locations
-
- Sheba Medical Center Ramat Gan, Israel
Not Yet Recruiting
Immunophenotypic Evaluation of CD305 and CD85d in B-Cell Lymphoid Neoplasms
NCT07499635
- Conditions
- B Cell Malignancies
- Locations
-
Not specified
Not Yet Recruiting
Exploratory Study on the Treatment of Relapsed and Refractory B-cell Malignant Tumors With WGb-0301 Injection
NCT07332663
- Conditions
- B Cell Malignancies
- Locations
-
Not specified
Not Yet Recruiting
Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)
NCT07166549
- Conditions
- B Cell Lymphoma, B Cell Malignancies, B-cell Leukemia, +25 more
- Locations
-
- University Hospital Basel, Division of Hematology or Medical Oncology Basel, Canton of Basel-City, Switzerland
Not Yet Recruiting
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Intravenous Anti-CD20/CD30-CAR-T Cell Infusion in Relapsed/Refractory Lymphoma Patients.
NCT06519344
- Conditions
- B Cell Malignancies
- Locations
-
Not specified
Completed
Evaluation of Prevalence and Risk Factors of Persistent COVID-19 in Immunocompromised Patients
NCT06576102
- Conditions
- B Cell Malignancies, COVID-19, Chronic Disease, +17 more
- Locations
-
- Irccs Aoubo Bologna, Italy
- IRCCS Humanitas Milan, Italy
- IRCCS INMI L. Spallanzani Roma, Italy
- AOUI Verona Verona, Italy
Active, Not Recruiting
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
NCT05618028
- Conditions
- B Cell Malignancies, Chronic Disease, Chronic Lymphocytic Leukemia, +21 more
- Locations
-
- University of California Los Angeles Medical Center /ID# 246357 Los Angeles, California, United States
- Yale University School of Medicine /ID# 259081 New Haven, Connecticut, United States
- Mount Sinai Medical Center-Miami Beach /ID# 248251 Miami Beach, Florida, United States
- Fort Wayne Medical Oncology and Hematology, Inc /ID# 250113 Fort Wayne, Indiana, United States